Compare Equinor ASA (EQNR) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Equinor ASA vs Oscar Health Inc — how do they compare? Equinor ASA trades at $43.02 (market cap $101.62B), while Oscar Health Inc trades at $33.4 (market cap $10.22B). The key difference: Equinor ASA is far larger — about 9.9× Oscar Health Inc's market cap, and Equinor ASA pays a 3.63% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Equinor ASA for 59 Days and Oscar Health Inc for 15 Days on average.
| EQNR | OSCR | |
|---|---|---|
Market Cap | $101.62B | $10.22B |
Volume | 4,991,782 | 4,123,394 |
Sector | Energy | Health |
52-Week High | $45.75 | $33.81 |
52-Week Low | $22.41 | $10.85 |
Typical Hold Time | 59 Days | 15 Days |
Enterprise Value | $110.31B | $6.57B |
Dividend Yield | 3.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Equinor (EQNR) trades at $43.01, up 3.36% today, with strong technical momentum indicated by bullish moving averages. The stock shows attractive valuation metrics with a P/E of 11.63 and EV/EBITDA of 2.39, while recent earnings beat expectations in two of the last three quarters. The company maintains solid profitability with 21.32% ROE and continues strategic expansion in LNG markets through new supply agreements.
EQNR presents compelling value with significant upside to the $87.50 consensus price target, though investors face risks from volatile energy prices and declining profit margins. The company's LNG expansion strategy and share buyback program provide catalysts, but execution risks and commodity price sensitivity require careful monitoring.
OSCR trades at $33.41, up 1.52% today, with a bullish technical signal and strong recent earnings beats in Q1 and Q2 2026. The stock shows robust revenue growth, with 2026 revenue projected at $15.3B and a return to profitability. Analyst sentiment is mixed but leans positive, with a consensus price target of $34.00. Recent news highlights market share gains and raised 2026 guidance, though the stock faces tests from rising medical costs.
The outlook is cautiously optimistic, driven by scalable growth in the ACA market and margin expansion opportunities. Key risks include medical cost pressures and competitive threats. Upside potential exists if the company executes on its 2029 EPS target of $4+, but investors should monitor profitability sustainability amid cost headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Equinor ASA
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
Read more on EQNR →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
